martes, 9 de junio de 2020

Longtime exec Tony Coles on biotech, racism, and opportunities for change

Longtime exec Tony Coles on biotech, racism, and opportunities for change

D.C. Diagnosis

Nicholas Florko

STAT stories you may have missed 

Wholesale drug prices — and net prices — keep falling for most drugs.
The University of Utah has “mutually agreed” to terminate the faculty appointment of Amit Patel, who was a co-author of two retracted papers on Covid-19 in the Lancet and the New England Journal of Medicine, STAT reports in an exclusive
Top takeaways from the medical conference ASCO, now virtual. 
The longtime biotech exec Tony Coles spoke with STAT about his industry, racism, and opportunities for change. 
Moderna’s decision to be vague about its in-development coronavirus vaccine was a matter of respecting federal securities laws and the rules of scientific journals, its CEO says. 
With the retractions of two Covid-19 papers from top journals, the scientific community is once again wrestling with the question that arises any time a high-profile publication blows up: Could this have been prevented?
Will the ‘patent dance’ cause Amgen to temporarily pull a biosimilar off the market?
Meet STACI: your interactive guide to the rapid advances of AI in health care. 

No hay comentarios: